# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k051733   
B. Purpose for Submission: New Device   
C. Measurand: Cortisol, Salivary   
D. Type of Test: Quantitative Enzyme Immunoassay   
E. Applicant: DRG International, Inc.   
F. Proprietary and Established Name DRG Salivary Cortisol ELISA KIT

# G. Regulatory Information:

1. Regulation section: 21 CFR §862.1205, Enzyme Immunoassay Cortisol, Salivary

2. Classification: Class II

3. Product code: NHG

4. Panel: 75 (Chemistry)

# H. Intended Use:

1. Intended use(s): See Indications for Use below.

2. Indication(s) for use:

The DRG Salivary Cortisol ELISA Test is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of active free cortisol (hydrocortisone and hydroxycorticosterone) in saliva. Measurements of cortisol are used in the diagnosis and treatment of disorders of the adrenal gland.

3. Special conditions for use statement(s): For prescription use.

4. Special instrument requirements:

Calibrated EIA reader adjusted to read at $4 5 0 \mathrm { n m }$ , Precision pipettes (100 and 200 µl), Distilled or Deionized water, Timer ( $\mathrm { 6 0 } \mathrm { m i n }$ . range), Reservoirs (disposable), Test tube or micro-tube rack in a microplate configuration, Linear-linear graph paper or software for data reduction.

# I. Device Description:

The DRG Salivary Cortisol ELISA Test consists of Microtiter plate, 8 well snap-off strips, 12 strips, coated with rabbit anti-Cortisol antiserum. Reference Standard Set, 1 ml each, 0.0; 2; 5; 10; 20; 40; $8 0 ~ \mathrm { n g / m l }$ . Enzyme-Conjugate, $2 6 ~ \mathrm { m l }$ , Cortisol conjugated to horseradish peroxidase. Substrate Solution –TMB, $2 5 ~ \mathrm { m l }$ . Stop Solution, and Wash Solution.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Salimetrics High Sensitivity Salivary Cortisol EIA KMI/ IBL Cortisol LIA

2. Predicate 510(k) number(s): k031348 - Salimetrics k010790 - KMI/ IBL

3. Comparison with predicate:

The DRG Salivary Cortisol Test is substantially equivalent to the Salimetrics HS Salivary Cortisol EIA (k031348). An additional comparison study was performed versus the KMI Diagnostics, Inc. Cortisol LIA method (k010790).

Comparison table for new device compared to the predicate devices   

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Predicate Device</td><td rowspan=1 colspan=1>Predicate Device</td><td rowspan=1 colspan=1>New Device</td></tr><tr><td rowspan=1 colspan=1>Device Name</td><td rowspan=1 colspan=1>Salimetrics HSSalivary CortisolEIA (k031348)</td><td rowspan=1 colspan=1>KMI/ IBL CortisolLIA (k010790)</td><td rowspan=1 colspan=1>DRG SalivaryCortisol ELISA(k051733)</td></tr><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Active Free Cortisol</td><td rowspan=1 colspan=1>Active Free Cortisol</td><td rowspan=1 colspan=1>Active Free Cortisol</td></tr><tr><td rowspan=1 colspan=1>Specimens</td><td rowspan=1 colspan=1>Saliva</td><td rowspan=1 colspan=1>Saliva and Serum</td><td rowspan=1 colspan=1>Saliva</td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Enzymeimmunoassay</td><td rowspan=1 colspan=1>Luminescentimmunoassay</td><td rowspan=1 colspan=1>Enzymeimmunoassay</td></tr><tr><td rowspan=1 colspan=1>Test Principle</td><td rowspan=1 colspan=1>Cortisol in thesample competeswith Cortisol-enzyme conjugatefor binding sites toantibody bound to amicrowell. Unboundcomponents arewashed away andbound cortisol-enzyme is measuredby a coloredreaction with theTMB substrate.</td><td rowspan=1 colspan=1>Same except,cortisol-peroxidaseis measured by achemiluminescentreading.</td><td rowspan=1 colspan=1>Same as cortisol-peroxidasemeasured by acolored reactionwith the TMBsubstrate.</td></tr><tr><td rowspan=1 colspan=1>Detection</td><td rowspan=1 colspan=1>Colorimetricmicroplate reader</td><td rowspan=1 colspan=1>Luminometer</td><td rowspan=1 colspan=1>Colorimetric reader</td></tr><tr><td rowspan=1 colspan=1>Calculation</td><td rowspan=1 colspan=1>Quantitativedetermination withstandard curve</td><td rowspan=1 colspan=1>Quantitativedetermination withstandard curve</td><td rowspan=1 colspan=1>Quantitativedetermination withstandard curve</td></tr><tr><td rowspan=1 colspan=1>Quality Control</td><td rowspan=1 colspan=1>Recommended</td><td rowspan=1 colspan=1>Recommended</td><td rowspan=1 colspan=1>Recommended</td></tr><tr><td rowspan=1 colspan=1>Indications for use</td><td rowspan=1 colspan=1>Measurements ofcortisol are used inthe diagnosis andtreatment ofdisorders of theadrenal gland.</td><td rowspan=1 colspan=1>Measurements ofcortisol are used inthe diagnosis andtreatment ofdisorders of theadrenal gland.</td><td rowspan=1 colspan=1>Measurements ofcortisol are used inthe diagnosis andtreatment ofdisorders of theadrenal gland.</td></tr><tr><td rowspan=1 colspan=1>Expected Values(Normal Range)</td><td rowspan=1 colspan=1>0.094 - 1.551 μg/dL</td><td rowspan=1 colspan=1>0.5 - 1.5 μg/dL</td><td rowspan=1 colspan=1>0.12 - 1.47 μg/dL</td></tr><tr><td rowspan=1 colspan=1>Detection limit</td><td rowspan=1 colspan=1>0.007 μg/dL</td><td rowspan=1 colspan=1>0.015 μg/dL</td><td rowspan=1 colspan=1>0.104 μg/dL</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

None referenced

# L. Test Principle:

The DRG Salivary Cortisol ELIA KIT is based on the competitive principle and the microplate separation. An unknown amount of Cortisol present in the sample and a fixed amount of Cortisol conjugated with horse-radish peroxidase compete for the binding sites of rabbit polyclonal Cortisol-antiserum coated onto the wells. After one hour incubation the microplate is washed to stop the competition reaction. After addition of the substrate solution the concentration of Cortisol is inversely proportional to the optical density measured.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

The Intra-Assay variation was determined by replicate measurements of 4 saliva samples using DRG ELISA kit. The within assay variation is shown below:

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Sample 1</td><td rowspan=1 colspan=1>Sample 2</td><td rowspan=1 colspan=1>Sample 3</td><td rowspan=1 colspan=1>Sample 4</td></tr><tr><td rowspan=1 colspan=1>Mean (ng/mL)</td><td rowspan=1 colspan=1>3.21 ng/mL</td><td rowspan=1 colspan=1>19.09 ng/mL</td><td rowspan=1 colspan=1>32.51 ng/mL</td><td rowspan=1 colspan=1>1.19 ng/mL</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.188</td><td rowspan=1 colspan=1>1.085</td><td rowspan=1 colspan=1>1.806</td><td rowspan=1 colspan=1>0.083</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>5.85</td><td rowspan=1 colspan=1>5.68</td><td rowspan=1 colspan=1>5.55</td><td rowspan=1 colspan=1>6.96</td></tr><tr><td rowspan=1 colspan=1>n =</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr></table>

The Inter-Assay (between-run) variation was determined by quadruplicate measurements of commercial control samples in three different day runs. The inter-assay variation is shown below:

<table><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>24.29 ng/mL</td><td rowspan=1 colspan=1>40.85 ng/mL</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>1.81 ng/mL</td><td rowspan=1 colspan=1>2.38 ng/mL</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>7.47</td><td rowspan=1 colspan=1>5.82</td></tr><tr><td rowspan=1 colspan=1>n =</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>12</td></tr></table>

The Inter-Lot (between-lot) variation was determined by duplicate measurements of five saliva samples in three different kit lots. The between run variability is shown below:

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Sample 1</td><td rowspan=1 colspan=1>Sample 2</td><td rowspan=1 colspan=1>Sample 3</td><td rowspan=1 colspan=1>Sample 4</td><td rowspan=1 colspan=1>Sample 5</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>2.17 ng/mL</td><td rowspan=1 colspan=1>14.01 ng/mL</td><td rowspan=1 colspan=1>22.85 ng/mL</td><td rowspan=1 colspan=1>1.74 ng/mL</td><td rowspan=1 colspan=1>2.03 ng/mL</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.12 ng/mL</td><td rowspan=1 colspan=1>1.17 ng/mL</td><td rowspan=1 colspan=1>1.44 ng/mL</td><td rowspan=1 colspan=1>0.13 ng/mL</td><td rowspan=1 colspan=1>0.15 ng/mL</td></tr><tr><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>5.50</td><td rowspan=1 colspan=1>8.32</td><td rowspan=1 colspan=1>6.29</td><td rowspan=1 colspan=1>7.56</td><td rowspan=1 colspan=1>7.43</td></tr><tr><td rowspan=1 colspan=1>n =</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>6</td></tr></table>

# b. Linearity/assay reportable range:

Three samples (saliva) containing different amounts of analyte were serially diluted 1:16 with zero standard and assayed with the DRG ELISA. The percentage recovery was calculated by comparing the expected and measured values for the SLV cortisol. An assay linearity of $1 . 0 4 - 7 7 \mathrm { n g / m L }$ has been identified as the usable range. Samples above this range must be diluted and re-run.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Sample 1</td><td rowspan=1 colspan=1>Sample 2</td><td rowspan=1 colspan=1>Sample 3</td></tr><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>ng/mL</td><td rowspan=1 colspan=1>33.13</td><td rowspan=1 colspan=1>80.0</td><td rowspan=1 colspan=1>24.32</td></tr><tr><td rowspan=1 colspan=1>AverageRecovery %</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>99.1</td><td rowspan=1 colspan=1>97.5</td></tr><tr><td rowspan=1 colspan=1>Range of</td><td rowspan=1 colspan=1>from</td><td rowspan=1 colspan=1>101.1</td><td rowspan=1 colspan=1>97.8</td><td rowspan=1 colspan=1>90.8</td></tr><tr><td rowspan=1 colspan=1>Recovery %</td><td rowspan=1 colspan=1>To</td><td rowspan=1 colspan=1>114.1</td><td rowspan=1 colspan=1>99.6</td><td rowspan=1 colspan=1>104.4</td></tr></table>

The Linearity study has been expanded to include additional higher samples to yield an upper detection level. As can be seen in the Table below the test is linear through to the highest Calibrator. Previous data demonstrated the lowest level of detectability.

# Upper Linearity Study

In order to identify the upper level of detectability, three (3) native saliva samples, containing different amounts of analyte, were spiked with purified cortisol to obtain a starting level (undiluted) around and above the highest Calibrator. The spiked saliva were serially diluted with zero standard and assayed to determine upper end of detectability with the DRG ELISA. The percentage recovery was calculated by comparing the expected and measured values for SLV cortisol.

Percentage recovery is calculated as follows:   
Measured values x 100   
Expected values

<table><tr><td rowspan=1 colspan=1>SpikedsalivaSample</td><td rowspan=1 colspan=1>Dilution</td><td rowspan=1 colspan=1>Measured ODmean of duplicate(450 nm)</td><td rowspan=1 colspan=1>Measured Conc.Cortisol Salivang/mL</td><td rowspan=1 colspan=1>Expected ConcCortisol Salivang/mL</td><td rowspan=1 colspan=1>Recovery(%)</td></tr><tr><td rowspan=8 colspan=1>Sample 1</td><td rowspan=1 colspan=1>undil</td><td rowspan=1 colspan=1>0.197</td><td rowspan=1 colspan=1>33.13</td><td rowspan=1 colspan=1>33.13</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>1 : 2</td><td rowspan=1 colspan=1>0.320</td><td rowspan=1 colspan=1>17.04</td><td rowspan=1 colspan=1>16.57</td><td rowspan=1 colspan=1>102.9</td></tr><tr><td rowspan=1 colspan=1>1 : 4</td><td rowspan=1 colspan=1>0.518</td><td rowspan=1 colspan=1>8.37</td><td rowspan=1 colspan=1>8.28</td><td rowspan=1 colspan=1>101.1</td></tr><tr><td rowspan=1 colspan=1>1 : 8</td><td rowspan=1 colspan=1>0.744</td><td rowspan=1 colspan=1>4.43</td><td rowspan=1 colspan=1>4.14</td><td rowspan=1 colspan=1>107.0</td></tr><tr><td rowspan=1 colspan=1>1:16</td><td rowspan=1 colspan=1>1.016</td><td rowspan=1 colspan=1>2.14</td><td rowspan=1 colspan=1>2.07</td><td rowspan=1 colspan=1>103.4</td></tr><tr><td rowspan=1 colspan=1>1:32</td><td rowspan=1 colspan=1>1.227</td><td rowspan=1 colspan=1>1.12</td><td rowspan=1 colspan=1>1.04</td><td rowspan=1 colspan=1>108.2</td></tr><tr><td rowspan=1 colspan=1>1:64</td><td rowspan=1 colspan=1>1.380</td><td rowspan=1 colspan=1>0.59</td><td rowspan=1 colspan=1>0.52</td><td rowspan=1 colspan=1>114.1</td></tr><tr><td rowspan=1 colspan=1>1:128</td><td rowspan=1 colspan=1>1.486</td><td rowspan=1 colspan=1>0.29</td><td rowspan=1 colspan=1>0.26</td><td rowspan=1 colspan=1>112.3</td></tr><tr><td rowspan=7 colspan=1>Sample 2</td><td rowspan=1 colspan=1>undil</td><td rowspan=1 colspan=1>0.066</td><td rowspan=1 colspan=1>80.00</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>1 : 2</td><td rowspan=1 colspan=1>0.084</td><td rowspan=1 colspan=1>80.00</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>1 : 4</td><td rowspan=1 colspan=1>0.111</td><td rowspan=1 colspan=1>73.36</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>1 : 8</td><td rowspan=1 colspan=1>0.183</td><td rowspan=1 colspan=1>36.47</td><td rowspan=1 colspan=1>36.68</td><td rowspan=1 colspan=1>99.4</td></tr><tr><td rowspan=1 colspan=1>1:16</td><td rowspan=1 colspan=1>0.305</td><td rowspan=1 colspan=1>18.22</td><td rowspan=1 colspan=1>18.34</td><td rowspan=1 colspan=1>99.3</td></tr><tr><td rowspan=1 colspan=1>1:32</td><td rowspan=1 colspan=1>0.490</td><td rowspan=1 colspan=1>9.13</td><td rowspan=1 colspan=1>9.17</td><td rowspan=1 colspan=1>99.6</td></tr><tr><td rowspan=1 colspan=1>1:64</td><td rowspan=1 colspan=1>0.740</td><td rowspan=1 colspan=1>4.48</td><td rowspan=1 colspan=1>4.58</td><td rowspan=1 colspan=1>97.8</td></tr><tr><td rowspan=6 colspan=1>sample3</td><td rowspan=1 colspan=1>undil</td><td rowspan=1 colspan=1>0.247</td><td rowspan=1 colspan=1>24.32</td><td rowspan=1 colspan=1>24.32</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>1 : 2</td><td rowspan=1 colspan=1>0.394</td><td rowspan=1 colspan=1>12.68</td><td rowspan=1 colspan=1>12.16</td><td rowspan=1 colspan=1>104.3</td></tr><tr><td rowspan=1 colspan=1>1 : 4</td><td rowspan=1 colspan=1>0.612</td><td rowspan=1 colspan=1>6.35</td><td rowspan=1 colspan=1>6.08</td><td rowspan=1 colspan=1>104.4</td></tr><tr><td rowspan=1 colspan=1>1 : 8</td><td rowspan=1 colspan=1>0.917</td><td rowspan=1 colspan=1>2.81</td><td rowspan=1 colspan=1>3.04</td><td rowspan=1 colspan=1>92.4</td></tr><tr><td rowspan=1 colspan=1>1:16</td><td rowspan=1 colspan=1>1.149</td><td rowspan=1 colspan=1>1.45</td><td rowspan=1 colspan=1>1.52</td><td rowspan=1 colspan=1>95.4</td></tr><tr><td rowspan=1 colspan=1>1:32</td><td rowspan=1 colspan=1>1.348</td><td rowspan=1 colspan=1>0.69</td><td rowspan=1 colspan=1>0.76</td><td rowspan=1 colspan=1>90.8</td></tr></table>

Sample 1 Sample 2 Sample 3   

<table><tr><td rowspan=1 colspan=1>Concentration   ng/mL</td><td rowspan=1 colspan=1>33.13</td><td rowspan=1 colspan=1>80.00</td><td rowspan=1 colspan=1>23.23</td></tr><tr><td rowspan=1 colspan=1>Average % Recovery</td><td rowspan=1 colspan=1>107.0</td><td rowspan=1 colspan=1>99.1</td><td rowspan=1 colspan=1>97.5</td></tr><tr><td rowspan=2 colspan=1>Range of         from% Recovery        to</td><td rowspan=1 colspan=1>101.1</td><td rowspan=1 colspan=1>97.8</td><td rowspan=1 colspan=1>92.4</td></tr><tr><td rowspan=1 colspan=1>114.0</td><td rowspan=1 colspan=1>99.6</td><td rowspan=1 colspan=1>104.4</td></tr></table>

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

The calibrators are buffer based (artificial saliva matrix). The calibrators were prepared by appropriate dilution from the maximum standard (Smax.: $8 0 ~ \mathrm { n g / m L }$ ). The Cortisol for the Calibrators was purchased from a commercially available source and is weighed in to make the $8 0 ~ \mathrm { n g / m L }$ .

The reference values (calibrators/controls) were established using (Gas chromatography-mass spectrophotometry) methods as per the guidelines for quality assurance in medical laboratories, Instand E.V. Germany ( L.D. Dikkesche. Et al. 1988: De toepassing van gaschromatografiemassaspectrometrie als referentiemethode in kwaliteitcontroleprogramma's voor progesterone-, cortisol-, testosteroneen oestradiolbepalingen in serums. Tijdschr NVKC 13: 148-155).

WHO standard is not available.

The functional quality of the kit lots were tested using the Lyphochek controls from BioRad, but controls are not included in the kit. These controls are commercially available and can be purchased by the customers.

# d. Detection limit:

The analytical sensitivity of the DRG ELISA was calculated by subtracting 2 standard deviations from the mean of 20 replicate analyses of the Zero Standard $\left( \mathbf { S } _ { 0 } \right)$ .

Standard curve:

Controls:   

<table><tr><td rowspan=1 colspan=1>Standard</td><td rowspan=1 colspan=1>Conc. ng/mL</td><td rowspan=1 colspan=1>OD450mean ofduplicate</td></tr><tr><td rowspan=1 colspan=1>SO</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2.05</td></tr><tr><td rowspan=1 colspan=1>S1</td><td rowspan=1 colspan=1>2,0</td><td rowspan=1 colspan=1>1.24</td></tr><tr><td rowspan=1 colspan=1>S2</td><td rowspan=1 colspan=1>5,0</td><td rowspan=1 colspan=1>0.85</td></tr><tr><td rowspan=1 colspan=1>S3</td><td rowspan=1 colspan=1>10,0</td><td rowspan=1 colspan=1>0.55</td></tr><tr><td rowspan=1 colspan=1>S4</td><td rowspan=1 colspan=1>20,0</td><td rowspan=1 colspan=1>0.33</td></tr><tr><td rowspan=1 colspan=1>S5</td><td rowspan=1 colspan=1>40,0</td><td rowspan=1 colspan=1>0.20</td></tr><tr><td rowspan=1 colspan=1>S6</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0.11</td></tr></table>

<table><tr><td></td><td>Conc. ng/ml</td><td>Acc. Range.</td></tr><tr><td>Lyphocheck 142/10</td><td>21.518</td><td>15.5 36.3</td></tr><tr><td>Lyphocheck 143/10</td><td>41.437</td><td>22.1 - 51.6</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Replicate</td><td rowspan=1 colspan=1>OD450of S0</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1.940</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>1.984</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>1.945</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>1.901</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>1.866</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>1.816</td></tr><tr><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>1.850</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>1.795</td></tr><tr><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1.963</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1.989</td></tr><tr><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>1.999</td></tr><tr><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>1.950</td></tr><tr><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1.975</td></tr><tr><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1.991</td></tr><tr><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1.927</td></tr><tr><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>1.927</td></tr><tr><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>2.066</td></tr><tr><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2.078</td></tr><tr><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1.818</td></tr><tr><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1.600</td></tr></table>

<table><tr><td>Mean = 1.919</td><td rowspan="3"></td></tr><tr><td>SD = 0.108</td></tr><tr><td>2xSD = 0.216</td></tr><tr><td>Mean - 2xSD</td><td>1.703 = 0.537 ng/mL</td></tr><tr><td>N =</td><td>20.00</td></tr></table>

# e. Analytical specificity:

Cross-reactivity was tested with the following compounds whose chemical structure could potentially cause interference with the SLV cortisol ELISA. The specificity of the antiserum used for the ELISA was evaluated by determination of the cross-reactivity at $50 \%$ displacement of various compounds listed in the table.

The cross reactivity is defined as:

Concentration of cortisol at $50 \%$ B/BO Concentration of cross-reactant giving $50 \%$ B/BO   

<table><tr><td colspan="1" rowspan="1">Steroid</td><td colspan="1" rowspan="1">% Cross Reaction</td></tr><tr><td colspan="1" rowspan="1">Cortisol</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Corticosterone</td><td colspan="1" rowspan="1">29%</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">3.00%</td></tr><tr><td colspan="1" rowspan="1">11-Deoxycortisol</td><td colspan="1" rowspan="1">&lt; 1,00%</td></tr><tr><td colspan="1" rowspan="1">17-OH Progesterone</td><td colspan="1" rowspan="1">&lt; 0,50%</td></tr><tr><td colspan="1" rowspan="1">Prednisone</td><td colspan="1" rowspan="1">&lt; 0, 10%</td></tr><tr><td colspan="1" rowspan="1">Progesterone</td><td colspan="1" rowspan="1">&lt; 0, 10%</td></tr><tr><td colspan="1" rowspan="1">Dexamethasone</td><td colspan="1" rowspan="1">&lt; 0, 10%</td></tr><tr><td colspan="1" rowspan="1">Desoxycorticosterone</td><td colspan="1" rowspan="1">&lt; 0, 10%</td></tr><tr><td colspan="1" rowspan="1">Dehydroepiandrosterone sulfate</td><td colspan="1" rowspan="1">&lt; 0, 10%</td></tr><tr><td colspan="1" rowspan="1">Estradiol</td><td colspan="1" rowspan="1">&lt; 0, 10%</td></tr><tr><td colspan="1" rowspan="1">Estriol</td><td colspan="1" rowspan="1">&lt; 0, 10%</td></tr><tr><td colspan="1" rowspan="1">Estrone</td><td colspan="1" rowspan="1">&lt; 0, 10%</td></tr><tr><td colspan="1" rowspan="1">Testosterone</td><td colspan="1" rowspan="1">&lt; 0, 10%</td></tr></table>

f. Assay cut-off: Not Applicable for this type of device.

2. Comparison studies:

a. Method comparison with predicate device:

Two studies were performed to evaluate the performance of the SLV Cortisol Saliva ELISA versus two commercially available saliva Cortisol kits.

One study evaluated saliva samples from 41 male and female subjects between ages $4 0 - 7 0$ years. The samples were run in duplicate on the DRG test and another commercially available LIA method to determine the concentration of Cortisol in the samples. An overall correlation of 0.9876 and a regression formula of $\mathbf { y } = 0 . 9 7 2 6 \mathbf { x } + 0 . 0 9 5$ was obtained versus this method. The samples ranged in concentration from 3.10 to $1 3 . 0 1 ~ \mathrm { n g / m L }$ .

A second study was performed using 30 saliva samples collected from men and women ages 40 – 65 years and run in duplicate on DRG and another commercially available EIA test. A correlation of 0.95742 with a regression formula of $\mathbf { y } = 0 . 9 8 1 2 \mathbf { x } + 0 . 1 5 1 5$ was observed. The samples ranged in concentration from $< 0 . 5$ to $1 1 . 8 6 ~ \mathrm { n g / m L }$ .

# $b$ . Matrix comparison:

Not applicable since this assay if for use with saliva samples only.

3. Clinical studies: a. Clinical Sensitivity: Not applicable $b$ . Clinical specificity:

Not applicable

c. Other clinical supportive data (when a. and b. are not applicable):

4. Clinical cut-off: Not applicable for this type of device

5. Expected values/Reference range:

109 saliva samples from apparently health adult male and female subjects, ranging in age from 20 to 80 years were collected in the morning and analyzed using the DRG SLV Cortisol ELISA kit. The salivary cortisol concentration did not show any significant differences based on age. Hence the normal range was calculated for the entire group. The normal range of salivary cortisol analyzed using DRG SLV Cortisol ELISA Test.

Adults: $0 . 1 2 - 1 . 4 7 ~ \mu \mathrm { g / d L }$ or $1 . 2 - 1 4 . 7 \mathrm { n g / m L }$ (AM collection)

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.